Literature DB >> 32245890

The short variant of optic atrophy 1 (OPA1) improves cell survival under oxidative stress.

Hakjoo Lee1, Sylvia B Smith2,3, Shey-Shing Sheu4, Yisang Yoon5.   

Abstract

Optic atrophy 1 (OPA1) is a dynamin protein that mediates mitochondrial fusion at the inner membrane. OPA1 is also necessary for maintaining the cristae and thus essential for supporting cellular energetics. OPA1 exists as membrane-anchored long form (L-OPA1) and short form (S-OPA1) that lacks the transmembrane region and is generated by cleavage of L-OPA1. Mitochondrial dysfunction and cellular stresses activate the inner membrane-associated zinc metallopeptidase OMA1 that cleaves L-OPA1, causing S-OPA1 accumulation. The prevailing notion has been that L-OPA1 is the functional form, whereas S-OPA1 is an inactive cleavage product in mammals, and that stress-induced OPA1 cleavage causes mitochondrial fragmentation and sensitizes cells to death. However, S-OPA1 contains all functional domains of dynamin proteins, suggesting that it has a physiological role. Indeed, we recently demonstrated that S-OPA1 can maintain cristae and energetics through its GTPase activity, despite lacking fusion activity. Here, applying oxidant insult that induces OPA1 cleavage, we show that cells unable to generate S-OPA1 are more sensitive to this stress under obligatory respiratory conditions, leading to necrotic death. These findings indicate that L-OPA1 and S-OPA1 differ in maintaining mitochondrial function. Mechanistically, we found that cells that exclusively express L-OPA1 generate more superoxide and are more sensitive to Ca2+-induced mitochondrial permeability transition, suggesting that S-OPA1, and not L-OPA1, protects against cellular stress. Importantly, silencing of OMA1 expression increased oxidant-induced cell death, indicating that stress-induced OPA1 cleavage supports cell survival. Our findings suggest that S-OPA1 generation by OPA1 cleavage is a survival mechanism in stressed cells.
© 2020 Lee et al.

Entities:  

Keywords:  OMA1 zinc metallopeptidase; OPA1; apoptosis; mitochondria; mitochondrial dynamics; mitochondrial permeability transition (MPT); necrosis (necrotic death); optic atrophy 1 (OPA1); oxidative stress; reactive oxygen species (ROS)

Mesh:

Substances:

Year:  2020        PMID: 32245890      PMCID: PMC7212625          DOI: 10.1074/jbc.RA119.010983

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  78 in total

1.  Down-regulation of OPA1 alters mouse mitochondrial morphology, PTP function, and cardiac adaptation to pressure overload.

Authors:  Jerome Piquereau; Fanny Caffin; Marta Novotova; Alexandre Prola; Anne Garnier; Philippe Mateo; Dominique Fortin; Le Ha Huynh; Valérie Nicolas; Marcel V Alavi; Catherine Brenner; Renée Ventura-Clapier; Vladimir Veksler; Frédéric Joubert
Journal:  Cardiovasc Res       Date:  2012-03-08       Impact factor: 10.787

2.  The human dynamin-related protein OPA1 is anchored to the mitochondrial inner membrane facing the inter-membrane space.

Authors:  Aurélien Olichon; Laurent J Emorine; Eric Descoins; Laetitia Pelloquin; Laetitia Brichese; Nicole Gas; Emmanuelle Guillou; Cécile Delettre; Annie Valette; Christian P Hamel; Bernard Ducommun; Guy Lenaers; Pascale Belenguer
Journal:  FEBS Lett       Date:  2002-07-17       Impact factor: 4.124

3.  m-AAA and i-AAA complexes coordinate to regulate OMA1, the stress-activated supervisor of mitochondrial dynamics.

Authors:  Francesco Consolato; Francesca Maltecca; Susanna Tulli; Irene Sambri; Giorgio Casari
Journal:  J Cell Sci       Date:  2018-04-09       Impact factor: 5.285

4.  Regulation of mitochondrial morphology through proteolytic cleavage of OPA1.

Authors:  Naotada Ishihara; Yuu Fujita; Toshihiko Oka; Katsuyoshi Mihara
Journal:  EMBO J       Date:  2006-06-15       Impact factor: 11.598

5.  Mutation spectrum and splicing variants in the OPA1 gene.

Authors:  C Delettre; J M Griffoin; J Kaplan; H Dollfus; B Lorenz; L Faivre; G Lenaers; P Belenguer; C P Hamel
Journal:  Hum Genet       Date:  2001-10-30       Impact factor: 4.132

6.  Nuclear gene OPA1, encoding a mitochondrial dynamin-related protein, is mutated in dominant optic atrophy.

Authors:  C Delettre; G Lenaers; J M Griffoin; N Gigarel; C Lorenzo; P Belenguer; L Pelloquin; J Grosgeorge; C Turc-Carel; E Perret; C Astarie-Dequeker; L Lasquellec; B Arnaud; B Ducommun; J Kaplan; C P Hamel
Journal:  Nat Genet       Date:  2000-10       Impact factor: 38.330

7.  Inhibition of PARP prevents oxidant-induced necrosis but not apoptosis in LLC-PK1 cells.

Authors:  D M Filipovic; X Meng; W B Reeves
Journal:  Am J Physiol       Date:  1999-09

8.  Mitochondrial fission mediates high glucose-induced cell death through elevated production of reactive oxygen species.

Authors:  Tianzheng Yu; Shey-Shing Sheu; James L Robotham; Yisang Yoon
Journal:  Cardiovasc Res       Date:  2008-04-25       Impact factor: 10.787

9.  Loss of OPA1 disturbs cellular calcium homeostasis and sensitizes for excitotoxicity.

Authors:  Y E Kushnareva; A A Gerencser; B Bossy; W-K Ju; A D White; J Waggoner; M H Ellisman; G Perkins; E Bossy-Wetzel
Journal:  Cell Death Differ       Date:  2012-11-09       Impact factor: 15.828

10.  OPA1 controls apoptotic cristae remodeling independently from mitochondrial fusion.

Authors:  Christian Frezza; Sara Cipolat; Olga Martins de Brito; Massimo Micaroni; Galina V Beznoussenko; Tomasz Rudka; Davide Bartoli; Roman S Polishuck; Nika N Danial; Bart De Strooper; Luca Scorrano
Journal:  Cell       Date:  2006-07-14       Impact factor: 41.582

View more
  12 in total

Review 1.  Mitochondrial dynamics regulators: implications for therapeutic intervention in cancer.

Authors:  Sanjay Kumar; Rahail Ashraf; Aparna C K
Journal:  Cell Biol Toxicol       Date:  2021-10-18       Impact factor: 6.691

Review 2.  Mitochondrial quality control in cardiac ischemia/reperfusion injury: new insights into mechanisms and implications.

Authors:  Yang Bai; Jinjing Wu; Zhenyu Yang; Xu'an Wang; Dongni Zhang; Jun Ma
Journal:  Cell Biol Toxicol       Date:  2022-08-11       Impact factor: 6.819

3.  Metabolic reprogramming in the OPA1-deficient cells.

Authors:  Wenting Dai; Zhichao Wang; Qiong A Wang; David Chan; Lei Jiang
Journal:  Cell Mol Life Sci       Date:  2022-09-14       Impact factor: 9.207

4.  Identification of new OPA1 cleavage site reveals that short isoforms regulate mitochondrial fusion.

Authors:  Ruohan Wang; Prashant Mishra; Spiros D Garbis; Annie Moradian; Michael J Sweredoski; David C Chan
Journal:  Mol Biol Cell       Date:  2020-11-25       Impact factor: 4.138

5.  Resveratrol protects retinal ganglion cells against ischemia induced damage by increasing Opa1 expression.

Authors:  Yulian Pang; Mengqi Qin; Piaopiao Hu; Kaibao Ji; Ruihan Xiao; Nan Sun; Xinghui Pan; Xu Zhang
Journal:  Int J Mol Med       Date:  2020-08-27       Impact factor: 4.101

Review 6.  Mitochondrial OMA1 and OPA1 as Gatekeepers of Organellar Structure/Function and Cellular Stress Response.

Authors:  Robert Gilkerson; Patrick De La Torre; Shaynah St Vallier
Journal:  Front Cell Dev Biol       Date:  2021-03-25

Review 7.  Mitochondrial Quality Control: A Pathophysiological Mechanism and Therapeutic Target for Stroke.

Authors:  Miaoxian Yang; Yu He; Shuixiang Deng; Lei Xiao; Mi Tian; Yuewen Xin; Chaocheng Lu; Feng Zhao; Ye Gong
Journal:  Front Mol Neurosci       Date:  2022-01-28       Impact factor: 5.639

Review 8.  Mitochondrial Dynamics, Mitophagy, and Mitochondria-Endoplasmic Reticulum Contact Sites Crosstalk Under Hypoxia.

Authors:  Shuying Wang; Jin Tan; Yuyang Miao; Qiang Zhang
Journal:  Front Cell Dev Biol       Date:  2022-02-25

Review 9.  Dominant Optic Atrophy (DOA): Modeling the Kaleidoscopic Roles of OPA1 in Mitochondrial Homeostasis.

Authors:  Valentina Del Dotto; Valerio Carelli
Journal:  Front Neurol       Date:  2021-06-09       Impact factor: 4.003

10.  Mitochondrial aberrations during the progression of disuse atrophy differentially affect male and female mice.

Authors:  Megan E Rosa-Caldwell; Seongkyun Lim; Wesley S Haynie; Jacob L Brown; David E Lee; Kirsten R Dunlap; Lisa T Jansen; Tyrone A Washington; Michael P Wiggs; Nicholas P Greene
Journal:  J Cachexia Sarcopenia Muscle       Date:  2021-09-29       Impact factor: 12.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.